NasdaqGM - Nasdaq Real Time Price USD
Xencor, Inc. (XNCR)
8.03
-0.11
(-1.35%)
As of 10:07:53 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
CORNELISSEN BART JAN Chief Financial Officer | Sale | Apr 10, 2025 | 61,348 |
DAHIYAT BASSIL ISHMAEL Chief Executive Officer | Sale | Mar 10, 2025 | 465,419 |
DESJARLAIS JOHN R Officer | Sale | Mar 10, 2025 | 236,574 |
ECKERT CELIA E General Counsel | Sale | Mar 10, 2025 | 63,507 |
GORMAN KEVIN CHARLES Director | Sale | Sep 27, 2024 | 8,392 |
GUSTAFSON KURT A Director | Sale | Sep 27, 2024 | 9,490 |
MONTGOMERY ALAN BRUCE Director | Sale | Dec 4, 2024 | 9,140 |
RANIERI RICHARD J Director | Sale | Sep 27, 2024 | 8,490 |
ROSA-BJORKESON DAGMAR Director | Sale | Sep 27, 2024 | 8,490 |
VALENTE NANCY M.D. Officer | Sale | May 2, 2025 | 49,169 |
Related Tickers
SYRE Spyre Therapeutics, Inc.
14.55
-1.72%
CGEM Cullinan Therapeutics, Inc.
7.02
-1.54%
KYMR Kymera Therapeutics, Inc.
29.60
-0.52%
ARTV Artiva Biotherapeutics, Inc.
1.8400
+1.66%
EWTX Edgewise Therapeutics, Inc.
14.28
-1.86%
JANX Janux Therapeutics, Inc.
23.30
+3.01%
ELVN Enliven Therapeutics, Inc.
19.39
-2.53%
ZYME Zymeworks Inc.
11.25
-0.04%
NRIX Nurix Therapeutics, Inc.
9.51
-0.73%
CDTX Cidara Therapeutics, Inc.
19.46
+0.80%